LENZ Therapeutics, Inc.
LENZNASDAQHealthcare● Active
$6.94
+$0.22(+3.20%)
Market Cap$217442722
P/E Ratio—
52W High$50.4
52W Low$6.61
LENZ Therapeutics, Inc.（LENZ）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · LENZ · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $292.35M | $209.03M | $65.79M | $44.44M | $18.31M |
| Net Receivables | $2.43M | $0.00M | $0.00M | $0.00M | $0.00M |
| Inventory | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Current Assets | $292.35M | $211.92M | $67.24M | $46.64M | $18.32M |
| PP&E Net | $0.00M | $1.99M | $0.37M | $0.28M | $0.01M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Assets | $305.88M | $215.30M | $70.38M | $46.95M | $18.34M |
| Liabilities | |||||
| Short-Term Debt | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Accounts Payable | $4.17M | $4.26M | $5.71M | $4.75M | $0.46M |
| Total Current Liabilities | $21.19M | $10.41M | $18.51M | $9.50M | $1.25M |
| Long-Term Debt | $0.35M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Liabilities | $21.54M | $11.22M | $163.09M | $71.12M | $32.55M |
| Stockholders Equity | |||||
| Retained Earnings | ($227.14M) | ($145.01M) | ($95.25M) | ($25.28M) | ($14.47M) |
| Total Stockholders Equity | $284.34M | $204.08M | ($92.71M) | ($24.17M) | ($14.21M) |
| Total Liab & Equity(computed) | $305.88M | $215.30M | $70.38M | $46.95M | $18.34M |
| Debt Summary | |||||
| Total Debt | $0.35M | $1.38M | $0.33M | $0.25M | $0.00M |
| Net Debt | ($24.83M) | ($18.78M) | ($34.81M) | ($44.19M) | ($18.31M) |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · M
深入了解LENZ Therapeutics, Inc.
关于LENZ Therapeutics, Inc.（LENZ）资产负债表
LENZ Therapeutics, Inc.总资产$0.31B，现金及短期投资$0.29B，总负债$0.02B，总债务$0.00B，股东权益$0.28B。
常见问题
LENZ · 4 问LENZ Therapeutics, Inc.总债务$0.00B，净债务($0.02B)。
LENZ total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10